Clinical Trial Update: The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effect of sevelamer carbonate on serum TMAO levels in patients with chronic kidney disease stage 3b-4. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

Sponsor: Fan Fan Hou | Conditions: CKD Stage 3b, CKD Stage 4 | Phase 3 | Status: UNKNOWN